In a cross-sectional study of steelworkers aged [45][46][47][48][49][50][51][52][53][54][55] years, smokers (n= 105; mean weight 76-1 kg) were found to weigh significantly less than non-smokers (n= 54; 81 6 kg) and ex-smokers (n=51; 82-6 kg). The lower weight of smokers was attributable to a group with airflow obstruction (n=37; forced expiratory volume in one second/vital capacity (FEV1/VC) <66%), who weighed less (4-8 kg; p <0 05) than smokers with normal FEV,/VC (n--68). In smokers, but not in ex-smokers or nonsmokers, body mass index and FEV1/VC ratio were closely related (r=0-34; p <0-001). This association was apparently not due to an effect of body weight on lung function.
Introduction
Differences in lung function between smokers and non-smokers are due to the presence among smokers of an appreciable minority of "susceptible" subjects. In these susceptible smokers the decline in lung function with age is more rapid than in nonsmokers and in most other smokers.1 On the other hand, nonsmoking men are on average slightly heavier than smokers, although this seems to be the case only in manual workers.2 There is evidence, mainly from the study of subjects who gained weight after stopping smoking, that these differences in body weight are due to an effect on metabolism rather than to suppression of appetite by smoking. The smokers were further classified (table II) according to whether or not they had an FEV,/VC ratio less than 66-6%-that is, lower than the one-sided 95 % limit derived from the data on the asymptomatic non-smokers. 4 The lower body mass index of the smokers was apparently fully accounted for by the lower body mass index (p < 0-005) ofthe subjects with airflow obstruction (FEV,/VC <66 60 ). This may be expressed another way (figure): in smokers the linear correlation of FEV,/VC and body mass index was highly significant (r=0 34; p < 0 001). In neither non-smokers nor ex-smokers was this correlation significant. No substantial changes in any of these correlations occurred when age, pack-years smoked, or time since giving up smoking were taken into account by computing partial correlations.
Body mass index and FEV,/VC ratio were comparable in asymptomatic non-smokers and smokers without airflow obstruction (p >0 05). 
Discussion
We found that among middle-aged steelworkers smokers weighed less than lifelong non-smokers and former smokers (table I). Our results agreed closely with those of Khosla and Lowe,10 who also studied steelworkers: most of their men were above the limits of desirable weights, smokers being on average lighter than non-smokers and ex-smokers. Khosla and Lowe, however, did not discuss the reason for these differences, nor did they mention any association with lung function findings. The novel observation in our study was that the lower weight and body mass index of smokers as a group was attributable to a subset of subjects with airflow obstruction, as evidenced by a low FEV1/VC ratio (table II) . Indeed, body mass index was comparable in non-smokers and smokers without airflow obstruction. Body mass index and FEV1/VC were highly significantly (p <0-001) correlated in smokers (figure) but not in non-smokers. It could be argued that the correlation coefficient was small and that therefore only a small part of the variances of these indices could be explained by their correlation. Nevertheless, this was not surprising in view of the many different determinants of body weight and lung function.
There are three possible explanations for the association: body weight may influence lung function, lung function may influence body weight, or both body weight and lung function may be influenced by one or more common factors. The first possibility-that body weight affects FEV1/VC-may be readily excluded, since there was no significant correlation between body mass index and FEV1/VC in non-smokers. This agrees with other data: the influence of body weight alone on lung function may be considered negligible within the range of the usual weights, since two opposite effects seem to operate. Increasing weight is accompanied to some extent by an improvement in lung function ("muscularity effect"), but with further increases in weight there is a decrease in lung function ("obesity effect")."' This results in a virtual plateau of the relation between FEVI/VC and body weight over the usual weights.1' 1' This was not so in our smokers, who showed a significant relation between body mass index and FEV1/VC ratio.
The second possibility may therefore be considered-that is, that impaired lung function caused the affected smokers to lose weight. Progressive weight loss occurs in patients with overt chronic obstructive lung disease and has been attributed to loss of appetite and reduced food intake,'3 to increased energy requirements,'4 or to reduced production of anabolic steroid hormones.'5 Our population of active smokers, however, was clearly different from the hospital populations in those studies.
Indeed, only four of our smokers had an FEV,/VC ratio below 50% (see figure) , and only three subjects reported shortness of breath when walking on a level floor. If lung function did influence body weight in these men (and there was little evidence to support this) our findings would mean that weight loss, which is,known to be an unfavourable prognostic factor in overt .chronic obstructive lung disease," 16 may well start quite early in the course of the disease. the third possibility is that body weight and loss of pulmonary function are influenced by some common factor or factors. For instance, subjects who are genetically susceptible to chronic obstructive lung disease may also be leaner than non-susceptible subjects. Leanness This complication of systemic lupus erythematosus has not been reported before. Laboratory studies and changes in lupus activity may fail to predict the onset of cholecystitis.
Introduction Mesenteric ischaemia, with or without bowel perforation, is reportedly the commonest acute abdominal complication of systemic lupus erythematosus,'l 2 and acute pancreatitis is also well documented.3 Vasculitis of the gall bladder presenting as an acute abdomen occurred in a patient with giant-cell arteritis,4 and gall-bladder disease may also occur in polyarteritis nodosa and allergic granulomatosis.5
We report a case of acute acalculous cholecystitis due to lupus vasculitis in a patient with severe systemic lupus erythematosus. This complication has not been reported before.
Case report A 22 year old woman presented with diffuse vasculitis of the skin. Serological tests suggested systemic lupus erythematosus, and LE cells were identified. Creatinine clearance was low (normal urinary sediment), and renal biopsy showed type 4 (WHO classification) lupus nephritis. Steroids and cyclophosphamide were begun. Repeat renal biopsy six months later showed a noticeable improvement, and the steroids were subsequently reduced and cyclophosphamide stopped.
